Vitros Afp
Kit, Test,Alpha-Fetoprotein For Testicular Cancer. 510(k) K213626, from Ortho Clinical Diagnostics (Pencoed, GB). Product code LOJ, class 2.
As of Nov 20, 2026, K213626 is an FDA 510(k) held by Ortho Clinical Diagnostics, substantially equivalent on Jun 15, 2022 after 210 days, with no recalls tied to it in FDA's recall database.
- Review time: 210 days
- Recalls: 0
For the quantitative measurement of alpha-fetoprotein (AFP) concentrations in human serum using the VITRO 5600 Integrated system to aid in the management of patients with non-seminomatous testicular cancer.
- Vitros Immunodiagnostic Products Afp AssayK983031 · Ortho-Clinical Diagnostics, Inc. · Dec 18, 1998
- Elecsys AFPK220176 · Roche Diagnostics · Sep 15, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 17, 2021
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files